• 2,5-di-tert-butylbenzene-1,4-diol (BHQ)

  2026-08-20

  A scenario-based guide to using 2,5-di-tert-butylbenzene-1,4-diol (BHQ), SKU B6648, in calcium signaling, viability, proliferation, and cytotoxicity workflows. It covers solvent compatibility, controls, interpretation limits, protocol design, and practical supplier-selection criteria.

• VE-821: From ATR Biology to Translational Strategy

  2026-08-20

  VE-821 offers a selective way to interrogate ATR–Chk1 checkpoint signaling, replication stress, radiosensitization, and combination therapy. This thought-leadership perspective connects established oncology applications with emerging epigenetic insights from human bocavirus research while clearly separating evidence from hypothesis.

• Hydroxychloroquine Sulfate Protocol Guide

  2026-08-19

  Hydroxychloroquine Sulfate (SKU B4874) provides an aqueous-compatible way to study autophagy pathway modulation and TLR7/9 signaling in autoimmune disease research. It is suited to short-term, water-based cell and animal workflows, but should not be selected when DMSO or ethanol solubility or long-term solution storage is required.

• DRD2 Variants and Pathogenic G-Protein Signaling

  2026-08-19

  A 2024 Biochemical Pharmacology study compared two pathogenic DRD2 variants associated with hyperkinetic movement disorders and identified enhanced constitutive and agonist-induced G-protein signaling as a likely explanation for their different clinical severity. Its combination of cellular pharmacology, arrestin and G-protein assays, cAMP measurements, thermal inactivation, and molecular dynamics provides a useful framework for interpreting disease-linked GPCR mutations.

• Pazopanib Hydrochloride: Assay Workflows

  2026-08-18

  Build more informative Pazopanib Hydrochloride response assays by separating growth inhibition from actual cell killing. This workflow combines target-informed dosing, time-resolved measurements, and troubleshooting guidance for renal cell carcinoma research, soft tissue sarcoma studies, and broader cancer research.

• Alternariol and LX-2 Fibrotic Reprogramming

  2026-08-18

  The reference study shows that Alternariol (AOH) and alternariol monomethyl ether can drive LX-2 hepatic stellate cells toward a contractile, myofibroblast-like phenotype, whereas tenuazonic acid produces no comparable response. By combining lncRNA-mRNA omics with pathway-focused validation, the work connects Alternaria toxin exposure with NF-κB signaling, ferroptosis, autophagy, and a proposed CotA laccase detoxification strategy.

• Br-DAPI for DNA Quantification and Cell Imaging

  2026-08-17

  Br-DAPI combines selective A/T-rich DNA binding with approximately 20-fold fluorescence enhancement for sensitive nuclear imaging and DNA measurement. Its membrane permeability supports both live-cell DNA staining and fixed-cell workflows, including cardiometabolic models of lipotoxicity and endoplasmic reticulum stress.

• Necrostatin 2: Reading Cell Death at the Membrane

  2026-08-17

  Necrostatin 2 (Nec-2) enables pathway-focused necroptosis inhibition while helping researchers distinguish kinase-dependent signaling from terminal plasma-membrane failure. This guide integrates product handling, assay design, ischemic stroke research, and insights from recent ferroptosis biology.

• Temafloxacin Activity Against Gram-Negative Bacteria

  2026-08-16

  This 1991 overview compared the in vitro activity of temafloxacin with ciprofloxacin and ofloxacin across respiratory, enteric, sexually transmitted, and other gram-negative pathogens. Its central contribution was to show broad and often high potency against many gram-negative organisms while identifying a meaningful limitation against Pseudomonas aeruginosa.

• Prevotella copri, IPA, and Breast Cancer Progression

  2026-08-15

  A 2024 Gut Microbes study identifies Prevotella copri as a microbiota-associated factor that can accelerate breast cancer growth by consuming host tryptophan and reducing intrinsic indole-3-pyruvic acid. The work connects this metabolic depletion to UHRF1 regulation and impaired AMPK signaling, providing a mechanistic framework for studying gut microbial control of tumor metabolism.

• Ertapenem: From Genotype to Phenotype in Resistance Assays

  2026-08-14

  Ertapenem sodium salt can serve as a mechanistic probe for connecting carbapenem resistance genes with measurable bacterial phenotypes. This article develops a genotype-to-phenotype assay framework grounded in recent CREC transmission research and practical compound-handling considerations.

• Mechanisms of Cell Death in Heart Disease

  2026-08-14

  This review reframes cardiac injury by showing that necrosis, like apoptosis, can be actively regulated rather than purely passive. Its pathway-based synthesis connects death-receptor signaling, mitochondria, endoplasmic reticulum stress, energy failure, and autophagy, providing a framework for interpreting myocardial infarction and heart failure research.

• Calcitriol: VDR Signaling and Research Use

  2026-08-13

  Calcitriol, also called 1,25-dihydroxy vitamin D3, is the active vitamin D3 metabolite that activates vitamin D receptor signaling. Its research value spans mineral homeostasis, immune modulation research, cytokine regulation, and cell-signaling assays, but its effects remain model- and dose-dependent.

• BCB Nanoassembly for Cuproptosis and Bone Metastasis

  2026-08-13

  The reference study develops a baicalein–copper nanoassembly containing a boron-dipyrromethene photosensitizer to combine chemodynamic therapy, photodynamic therapy, and cuproptosis. Its key practical contribution is the integration of tumor-microenvironment-responsive copper delivery, reactive oxygen species generation, and bone-site accumulation in a preclinical melanoma model.

• AMPK–SQSTM1 Feedback Under Metabolic Stress

  2026-08-12

  The 2024 Autophagy study identifies a double-positive feedback loop between AMPK and SQSTM1/p62 that jointly activates AMPK and NFE2L2/NRF2 during metabolic stress. Its findings connect lysosomal acidification, TFEB/TFE3, TAK1, KEAP1 degradation, and antioxidant defense, offering a mechanistic framework for stress adaptation in STK11/LKB1- and KEAP1-altered lung cancer.

15902 records 1/1061 page Next 12345 下5页 Last page